Philips Launches Duo Venous Stent System For Treatment Of Symptomatic Venous Outflow Obstruction In Patients With CVI
Portfolio Pulse from Benzinga Newsdesk
Philips has launched the Duo Venous Stent System for treating symptomatic venous outflow obstruction in patients with chronic venous insufficiency (CVI). The first patient was treated at Sanger Heart & Vascular Institute, Atrium Health, following FDA premarket approval.
June 12, 2024 | 1:03 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Philips has introduced the Duo Venous Stent System for treating CVI, with the first patient treated post-FDA approval. This development could enhance Philips' market position in the medical device sector.
The launch of the Duo Venous Stent System and its FDA approval are significant milestones for Philips, likely boosting its market position and potentially driving short-term stock price appreciation.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100